In conclusion, various HERV genes including HERV-R (ERV3-1), HERV-H, and HERV-P env show the same pattern of regulation as HERV-K (HML-2) and may be potent diagnostic markers and therapeutic targets for breast cancer patients. This evidence concerns the gene ERV3-1 and breast carcinoma.